157 related articles for article (PubMed ID: 15726543)
1. Clinicopathologic and protein expression differences between cardia carcinoma and noncardia carcinoma of the stomach.
Kim MA; Lee HS; Yang HK; Kim WH
Cancer; 2005 Apr; 103(7):1439-46. PubMed ID: 15726543
[TBL] [Abstract][Full Text] [Related]
2. Mucinous gastric carcinomas: clinicopathologic and molecular analyses.
Choi JS; Kim MA; Lee HE; Lee HS; Kim WH
Cancer; 2009 Aug; 115(15):3581-90. PubMed ID: 19479974
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features of adenocarcinoma at the gastric cardia: is it different from distal cancer of the stomach?
Maeda H; Okabayashi T; Nishimori I; Sugimoto T; Namikawa T; Dabanaka K; Tsujii S; Onishi S; Kobayashi M; Hanazaki K
J Am Coll Surg; 2008 Feb; 206(2):306-10. PubMed ID: 18222384
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics and prognosis of carcinoma of the gastric cardia.
Kim DY; Joo JK; Ryu SY; Park YK; Kim YJ; Kim SK
Dig Surg; 2006; 23(5-6):313-8. PubMed ID: 17164543
[TBL] [Abstract][Full Text] [Related]
5. Proposal for a new definition of true cardia carcinoma.
Ichikura T; Chochi K; Sugasawa H; Mochizuki H
J Surg Oncol; 2007 Jun; 95(7):561-6. PubMed ID: 17192914
[TBL] [Abstract][Full Text] [Related]
6. [Goseki classification in adenocarcinoma of the cardia].
De Manzoni G; Pedrazzani C; Di Leo A; Bonfiglio M; Zerman G; Tasselli S; Borzellino G
Minerva Chir; 2002 Aug; 57(4):449-55. PubMed ID: 12145574
[TBL] [Abstract][Full Text] [Related]
7. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity and immunohistochemistry of adenocarcinomas of the esophagus and gastric cardia.
Marsman WA; Birjmohun RS; van Rees BP; Caspers E; Johan G; Offerhaus A; Bosma PJ; Jan J; van Lanschot B
Clin Cancer Res; 2004 Dec; 10(24):8479-85. PubMed ID: 15623628
[TBL] [Abstract][Full Text] [Related]
9. The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays.
Li XH; Zheng HC; Wang ZG; Takahashi H; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(2A):1061-7. PubMed ID: 18507055
[TBL] [Abstract][Full Text] [Related]
10. Early carcinoma of the gastric cardia in Japan: is it different from that in the West?
Okabayashi T; Gotoda T; Kondo H; Inui T; Ono H; Saito D; Yoshida S; Sasako M; Shimoda T
Cancer; 2000 Dec; 89(12):2555-9. PubMed ID: 11135215
[TBL] [Abstract][Full Text] [Related]
11. Combined evaluation of expressions of cyclin E and p53 proteins as prognostic factors for patients with gastric cancer.
Bani-Hani KE; Almasri NM; Khader YS; Sheyab FM; Karam HN
Clin Cancer Res; 2005 Feb; 11(4):1447-53. PubMed ID: 15746045
[TBL] [Abstract][Full Text] [Related]
12. TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival.
Vagenas K; Spyropoulos C; Gavala V; Tsamandas AC
J Surg Res; 2007 May; 139(2):182-8. PubMed ID: 17270215
[TBL] [Abstract][Full Text] [Related]
13. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers.
Boo YJ; Park SS; Kim JH; Mok YJ; Kim SJ; Kim CS
J Surg Oncol; 2007 Feb; 95(2):110-7. PubMed ID: 17066436
[TBL] [Abstract][Full Text] [Related]
14. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
[TBL] [Abstract][Full Text] [Related]
15. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
16. Integrin alphanvbeta6 acts as a prognostic indicator in gastric carcinoma.
Zhang ZY; Xu KS; Wang JS; Yang GY; Wang W; Wang JY; Niu WB; Liu EY; Mi YT; Niu J
Clin Oncol (R Coll Radiol); 2008 Feb; 20(1):61-6. PubMed ID: 17981018
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
[TBL] [Abstract][Full Text] [Related]
18. High expression of HER3 is associated with a decreased survival in gastric cancer.
Hayashi M; Inokuchi M; Takagi Y; Yamada H; Kojima K; Kumagai J; Kawano T; Sugihara K
Clin Cancer Res; 2008 Dec; 14(23):7843-9. PubMed ID: 19047113
[TBL] [Abstract][Full Text] [Related]
19. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus.
Kusano M; Toyota M; Suzuki H; Akino K; Aoki F; Fujita M; Hosokawa M; Shinomura Y; Imai K; Tokino T
Cancer; 2006 Apr; 106(7):1467-79. PubMed ID: 16518809
[TBL] [Abstract][Full Text] [Related]
20. Survival stratification panel of colorectal carcinoma with combined expression of carcinoembryonic antigen, matrix metalloproteinases-2, and p27 kip1.
Li M; Li JY; Zhao AL; He JS; Zhou LX; Li YA; Gu J
Dis Colon Rectum; 2007 Nov; 50(11):1887-98. PubMed ID: 17882488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
